These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 9630182

  • 1. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency.
    Zhou H, Fischer HP.
    Am J Surg Pathol; 1998 Jun; 22(6):742-8. PubMed ID: 9630182
    [Abstract] [Full Text] [Related]

  • 2. Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma?
    Zhou H, Ortiz-Pallardó ME, Ko Y, Fischer HP.
    Cancer; 2000 Jun 15; 88(12):2668-76. PubMed ID: 10870048
    [Abstract] [Full Text] [Related]

  • 3. Chronic liver disease in heterozygous alpha1-antitrypsin deficiency PiZ.
    Fischer HP, Ortiz-Pallardó ME, Ko Y, Esch C, Zhou H.
    J Hepatol; 2000 Dec 15; 33(6):883-92. PubMed ID: 11131449
    [Abstract] [Full Text] [Related]

  • 4. [Liver changes in heterozygote alpha 1-antitrypsin deficiency PiZ].
    Zhou H, Fischer HP.
    Pathologe; 2000 Nov 15; 21(6):433-40. PubMed ID: 11148823
    [Abstract] [Full Text] [Related]

  • 5. Alpha-1-antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human.
    Giovannoni I, Callea F, Stefanelli M, Mariani R, Santorelli FM, Francalanci P.
    Liver Int; 2015 Jan 15; 35(1):198-206. PubMed ID: 24529185
    [Abstract] [Full Text] [Related]

  • 6. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
    Rudnick DA, Liao Y, An JK, Muglia LJ, Perlmutter DH, Teckman JH.
    Hepatology; 2004 Apr 15; 39(4):1048-55. PubMed ID: 15057909
    [Abstract] [Full Text] [Related]

  • 7. Identification of PiZ gene products in liver tissue by a monoclonal antibody specific for the Z mutant of alpha 1-antitrypsin.
    Callea F, Brisigotti M, Faa G, Lucini L, Eriksson S.
    J Hepatol; 1991 May 15; 12(3):372-6. PubMed ID: 1940268
    [Abstract] [Full Text] [Related]

  • 8. Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis.
    Elzouki AN, Hultcrantz R, Stål P, Befrits R, Eriksson S.
    Gut; 1995 Jun 15; 36(6):922-6. PubMed ID: 7615285
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma.
    Rabinovitz M, Gavaler JS, Kelly RH, Prieto M, Van Thiel DH.
    Hepatology; 1992 Mar 15; 15(3):407-10. PubMed ID: 1312055
    [Abstract] [Full Text] [Related]

  • 11. Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study.
    Francalanci P, Santorelli FM, Saccani S, Bonetti MF, Medicina D, Coni P, Faa G, Callea F.
    Liver Int; 2009 Nov 15; 29(10):1593-6. PubMed ID: 19744266
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Α₁-antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease.
    Goltz D, Hittetiya K, Vössing LM, Kirfel J, Spengler U, Fischer HP.
    Virchows Arch; 2014 Nov 15; 465(5):539-46. PubMed ID: 25070245
    [Abstract] [Full Text] [Related]

  • 14. Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.
    Brunt EM, Blomenkamp K, Ahmed M, Ali F, Marcus N, Teckman J.
    J Pediatr Gastroenterol Nutr; 2010 Nov 15; 51(5):626-30. PubMed ID: 20890217
    [Abstract] [Full Text] [Related]

  • 15. Oxidative stress contributes to liver damage in a murine model of alpha-1-antitrypsin deficiency.
    Marcus NY, Blomenkamp K, Ahmad M, Teckman JH.
    Exp Biol Med (Maywood); 2012 Oct 15; 237(10):1163-72. PubMed ID: 23104507
    [Abstract] [Full Text] [Related]

  • 16. Detection of alpha-1-antitrypsin PiZ individuals by SSCP and DNA sequencing in formalin-fixed and paraffin-embedded tissue: a comparison with immunohistochemical analysis.
    Ortiz-Pallardó ME, Ko Y, Sachinidis A, Vetter H, Fischer HP, Zhou H.
    J Hepatol; 2000 Mar 15; 32(3):406-11. PubMed ID: 10735609
    [Abstract] [Full Text] [Related]

  • 17. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
    Borel F, Tang Q, Gernoux G, Greer C, Wang Z, Barzel A, Kay MA, Shultz LD, Greiner DL, Flotte TR, Brehm MA, Mueller C.
    Mol Ther; 2017 Nov 01; 25(11):2477-2489. PubMed ID: 29032169
    [Abstract] [Full Text] [Related]

  • 18. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
    Regev A, Guaqueta C, Molina EG, Conrad A, Mishra V, Brantly ML, Torres M, De Medina M, Tzakis AG, Schiff ER.
    J Pediatr Gastroenterol Nutr; 2006 Jul 01; 43 Suppl 1():S30-5. PubMed ID: 16819398
    [Abstract] [Full Text] [Related]

  • 19. Retrospective analysis of children with α-1 antitrypsin deficiency.
    Comba A, Demirbaş F, Çaltepe G, Eren E, Kalayci AG.
    Eur J Gastroenterol Hepatol; 2018 Jul 01; 30(7):774-778. PubMed ID: 29505478
    [Abstract] [Full Text] [Related]

  • 20. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
    Smanadhikorn P, Pongpaew P, Srivatanakul P, Tungtrongchitr R, Supanaranond W, Schelp FP, Migasena P.
    Southeast Asian J Trop Med Public Health; 1995 Jun 01; 26(2):240-2. PubMed ID: 8629052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.